NEW YORK, Aug. 23 – Rosetta Inpharmatics has licensed its Resolver gene expression data analyzer to functional genomics company Europroteome, Rosetta said on Thursday.

Europroteome, based in Hennigsdorf, Germany, will use the system to help it manage and analyze genomic data for its research in epithelial cancers.

Terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.